Home > Quotes > XBI

SPDR S&P Biotech ETF Stock Quote & Summary Data

Get XBI Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading XBI now

Community Rating:
View:    XBI After Hours
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
ETF Headlines Market Stream
Short Interest Dividend History
 Save Stocks
1 Year Target
Today's High /Low  / 
Share Volume
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 497,431
Previous Close $ 204.67
52 Week High/Low $ 206.72 / $ 115.3117
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 1,752,872,000
Annualized dividend $ 1.964
Ex Dividend Date Dec. 19, 2014
Dividend Payment Date Dec. 30, 2014
Current Yield 0.96 %
Beta 0

Intraday Chart


The SPDR S&P Biotech ETF seeks to replicate as closely as possible, before expenses, the performance of the S&P Biotechnology Select Industry Index (the "Index"). The Index represents the biotechnology sub-industry portion of the S&P Total Stock Market Index. The Index is one of nineteen (19) of the S&P Select Industry Indexes, each designed to measure the performance of a narrow sub-industry determined based on the Global Industry Classification Standards (GICS). The Index consists of the S&P Select Industry Indexes constituents belonging to the particular GICS sub-industry (e.g., biotechnology) that satisfy the following criteria: (i) rank within the 90th percentile of the float-adjusted market capitalization of the GICS sub-industry; (ii) are a U.S.-based company; and (iii) have a liquidity ratio greater than 60%. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

Underlying Index S&P Biotechnology Select Industry Index
Management Fee 0.35
Asset Class Equity
Leverage 1

News for XBI

Top Holdings
INSM Insmed Inc 1.9%
VRTX Vertex Pharmaceuticals Inc 1.62%
GEVA Synageva Biopharma Corp 1.56%
NLNK Newlink Genetics Corp 1.5%
ARWR Arrowhead Research Corp 1.46%
INO Inovio Pharmaceuticals 1.41%
RGEN Repligen Corp 1.41%
VNDA Vanda Pharmaceuticals Inc 1.41%
ALKS Alkermes Plc 1.39%
ISIS Isis Pharmaceuticals 1.37%

Research Brokers before you trade

Want to trade FX?